Harwin Peter Evan
Reporting owner on Forms 3, 4 and 5, CIK 1663607.
- In the filer group Fairmount Funds Management LLC
Harwin Peter Evan reported on 2 issuers in 5 filings, the latest a 13D filed 2026-11-12.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| TCRT · Alaunos Therapeutics, Inc.CIK 1107421 | director, 10% owner | 1 | 2026-10-15 |
| InMed Pharmaceuticals Inc. CIK 1728328 | 10% owner | 1 | 2026-11-12 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc. Common Stock, holding | 10,555,507 | Form 3 | ||||
| InMed Pharmaceuticals Inc. Series A Non-Voting Preferred Stock, derivative, holding | Form 3 | |||||
| InMed Pharmaceuticals Inc. Pre-funded Warrant, derivative, holding | Form 3 | |||||
| TCRT · Alaunos Therapeutics, Inc.Common Stock, holding | 687,789 | Form 3 | ||||
| TCRT · Alaunos Therapeutics, Inc.Series B Preferred Stock, derivative, holding | Form 3 | |||||
| TCRT · Alaunos Therapeutics, Inc.Series C Preferred Stock, derivative, holding | Form 3 | |||||
| TCRT · Alaunos Therapeutics, Inc.Series C Preferred Stock, derivative, holding | Form 3 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13D 0001193125-26-458677 | MTRI | 2026-11-12 | ||
| Form 3 0001193125-26-458262 | InMed Pharmaceuticals Inc. | 2026-11-12 | ||
| Form 3 0001683168-26-007900 | Alaunos Therapeutics, Inc. | 2026-10-15 | ||
| 13D 0001683168-26-007898 | TCRT | 2026-10-15 | ||
| 13D/A 0001104659-26-115087 | SYRE | 2026-10-09 |